Cargando…
A Case of Multidrug-Resistant Klebsiella pneumoniae Treated with Carrimycin
One of the most pressing emerging issues in bacterial resistance is multidrug-resistant Klebsiella pneumoniae. The treatment of K. pneumoniae infections is often problematic because of the lack of available therapeutic options, leading to negative effects on morbidity, mortality, and healthcare-asso...
Autores principales: | Zhu, Wenjun, Tian, Yaping, Xiang, Lin, Cao, Linna, He, Lirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126721/ https://www.ncbi.nlm.nih.gov/pubmed/37113529 http://dx.doi.org/10.2147/IDR.S407076 |
Ejemplares similares
-
Anti-inflammatory effect and antihepatoma mechanism of carrimycin
por: Li, Xiu-Yan, et al.
Publicado: (2023) -
Molecular characterization of multidrug-resistant Klebsiella
pneumoniae isolates
por: Hou, Xiang-hua, et al.
Publicado: (2015) -
The secondary resistome of multidrug-resistant Klebsiella pneumoniae
por: Jana, Bimal, et al.
Publicado: (2017) -
Acute-onset postoperative endophthalmitis caused by multidrug-resistant Klebsiella pneumoniae
por: Sanghi, Shekhar, et al.
Publicado: (2014) -
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Jin, Yong, et al.
Publicado: (2021)